4,45 €
- Jan.
- Feb.
- März
- Apr.
- Mai
- Juni
- Aug.
- Sept.
- 4.00
- 4.50
- 5.00
- 5.40
- 5.90
ERTRÄGE
Warnung: Die Dividende wurde um 65,1% gekürzt auf 0,11 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.
0,11 €
Jährliche Dividende
2,48 %
Rendite
-65,07 %
Dividenden-Wachstum
45,11 %
Ausschüttungsquote
UNTERNEHMEN
17,8 Mrd. SEK
Umsatz
-0,99 %
Umsatz-Wachstum
274,0 Mio. SEK
Nettogewinn
-
2,8 %
ROE -
1,5 %
ROS -
0,9 %
ROA -
12,2 %
GPM
3,0 Mrd. SEK
Operativer Cashflow
9,8 Mrd. SEK
Eigenkapital
4.541
Mitarbeiter
-
3,9 Mio. SEK
Umsatz / MA -
60.339,1 SEK
Gewinn / MA
KGV
67,00 SEKKBV
1,87 SEKKCV
11,58 SEKKUV
1,03 SEKEV/EBITDA
16,65 SEKEV/EBIT
38,80 SEKEV/FCF
22,89 SEKEV/Umsatz
2,03 SEKEnterpriseValue
36,3 Mrd. SEKEigenkapitalrendite
2,79 %Umsatzrendite
1,54 %EBIT-Marge
5,24 %EBITDA-Marge
12,22 %Kapitalumschlag
0,58 SEKGesamtkapitalrendite
0,89 %Eigenkapitalquote
0,32 SEKFremdkapitalquote
0,68 SEKVerschuldungsgrad
2,15 SEKDyn. Verschuldungsgrad
6,95 SEKSachinvestitionsquote
-0,15 SEKAnlagendeckungsgrad 1
1,71 SEKAnlagendeckungsgrad 2
0,95 SEKLiquidität 1. Grades
0,24 SEKLiquidität 2. Grades
0,53 SEKLiquidität 3. Grades
1,06 SEKDividende pro Aktie
0,32 SEKDividendenrendite
0,67 %Ausschüttungsquote
45,11 %Buchwert pro Aktie
25,65 SEKCashflow pro Aktie
7,92 SEKStand: 31.07.2025 TTM
Fakten
-
Sitz
Schweden
-
Hauptsitz
Stockholm
-
Börsengang
26.04.2010
-
Ausstehende Aktien
382,91 Mio.
-
Mitarbeiter
4,54 Tsd.
-
Währung
SEK
-
Sektor
Gesundheitswesen
-
Industrie
Medical - Instruments & Supplies
-
Börse
OTC
-
Ticker
EKTAF
-
Webseite
Aktie
Unternehmensinfos
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma...
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.